Login

Erik Briers

ORCID: 0000-0002-7267-8449
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
A5019052630
Research Areas
  • Prostate Cancer Treatment and Research
  • Prostate Cancer Diagnosis and Treatment
  • Health Systems, Economic Evaluations, Quality of Life
  • Bladder and Urothelial Cancer Treatments
  • Urologic and reproductive health conditions
  • Hormonal and reproductive studies
  • Colorectal Cancer Screening and Detection
  • Effects of Radiation Exposure
  • Global Cancer Incidence and Screening
  • Radiology practices and education
  • Advances in Oncology and Radiotherapy
  • Advanced Radiotherapy Techniques
  • Economic and Financial Impacts of Cancer
  • Cancer survivorship and care
  • Clinical practice guidelines implementation
  • Lung Cancer Diagnosis and Treatment
  • Radiomics and Machine Learning in Medical Imaging
  • Cancer, Lipids, and Metabolism
  • Head and Neck Cancer Studies
  • Patient Satisfaction in Healthcare
  • Radiation Dose and Imaging
  • Lung Cancer Treatments and Mutations
  • Venous Thromboembolism Diagnosis and Management
  • Reliability and Agreement in Measurement
  • Meta-analysis and systematic reviews

European Association of Urology
 2024

Vlaams Patiëntenplatform
 2023

European CanCer Organisation
 2020-2023

European Society of Radiology
 2023

 EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
OPENALEX - Publications 
Nicolas Mottet Joaquim Bellmunt M. Bolla Erik Briers Marcus Cumberbatch and 17 more Maria De Santis Nicola Fossati Tobias Gross Ann Henry Steven Joniau Thomas Lam Malcolm D. Mason В. Б. Матвеев Paul C. Moldovan Roderick C.N. van den Bergh Thomas Van den Broeck Henk G. van der Poel Theodorus van der Kwast Olivier Rouvière Ivo G. Schoots Thomas Wiegel Philip Cornford

10.1016/j.eururo.2016.08.003 article EN European Urology 2016-08-31
 EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer
OPENALEX - Publications 
Philip Cornford Joaquim Bellmunt M. Bolla Erik Briers Maria De Santis and 10 more Tobias Gross Ann Henry Steven Joniau Thomas Lam Malcolm D. Mason Henk G. van der Poel Theodorus van der Kwast Olivier Rouvière Thomas Wiegel Nicolas Mottet

10.1016/j.eururo.2016.08.002 article EN European Urology 2016-09-09
 Policy statement on multidisciplinary cancer care
OPENALEX - Publications 
Josep M. Borràs Tit Albreht Riccardo A. Audisio Erik Briers Paolo G. Casali and 21 more Hélène Esperou Birgitte Grube Marc Hamoir Geoffrey Henning Joan Kelly Susan Knox María Nabal Marco A. Pierotti Claudio Lombardo Wim H. van Harten Graeme J. Poston Joan Prades Milena Sant Luzia Travado Vincenzo Valentini Cornelis J.�H. van de Velde Saskia Van den Bogaert Marc Van den Bulcke Elke Van Hoof Ingrid van den Neucker Robin Wilson

10.1016/j.ejca.2013.11.012 article EN European Journal of Cancer 2013-12-06
 Biochemical Recurrence in Prostate Cancer: The European Association of Urology Prostate Cancer Guidelines Panel Recommendations
OPENALEX - Publications 
Thomas Van den Broeck Roderick C.N. van den Bergh Erik Briers Philip Cornford Marcus Cumberbatch and 19 more Derya Tilki Maria De Santis Stefano Fanti Nicola Fossati Silke Gillessen Jeremy Grummet Ann Henry Michael Lardas Matthew Liew Malcolm D. Mason Lisa Moris Ivo G. Schoots Theodorus van der Kwast Henk G. van der Poel Thomas Wiegel Peter-Paul M. Willemse Olivier Rouvière Thomas Lam Nicolas Mottet

10.1016/j.euf.2019.06.004 article EN European Urology Focus 2019-06-24
 Focal Therapy in Primary Localised Prostate Cancer : The European Association of Urology Position in 2018
OPENALEX - Publications 
Henk G. van der Poel Roderick C.N. van den Bergh Erik Briers Philip Cornford Alex Govorov and 8 more Ann Henry Thomas Lam Malcolm D. Mason Olivier Rouvière Maria De Santis Peter-Paul Willemse Hendrik Van Poppel Nicolas Mottet

10.1016/j.eururo.2018.01.001 article EN European Urology 2018-01-17
 REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer
OPENALEX - Publications 
Petra Seibold Adam Webb Miguel E. Aguado‐Barrera D. Azria C. Bourgier and 95 more Muriel Brengues Erik Briers Renée Bultijnck Patricia Calvo Ana M. Carballo Ananya Choudhury A. Cicchetti Johannes Claßen E. Delmastro Alison M. Dunning Rebecca Elliott Laura Fachal Marie‐Pierre Farcy‐Jacquet P. Gabriele E. Garibaldi Antonio Gómez‐Caamaño Sara Gutiérrez‐Enríquez Daniel S. Higginson Kerstie Johnson Ramón Lobato-Busto Meritxell Mollà Anusha Müller Debbie Payne Paula Peleteiro Giselle Post T. Rancati Tim Rattay Victoria Reyes Barry S. Rosenstein Dirk De Ruysscher Maria Carmen De Santis Jörg Schäfer Thomas Schnabel Elena Sperk R.P. Symonds Hilary Stobart Begoña Taboada‐Valladares Chris J. Talbot R. Valdagni Ana Vega Liv Veldeman Tim Ward Christian Weißenberger Catharine West Jenny Chang‐Claude Yolande Lievens M. Van Eijkeren Katrien Vandecasteele Elhaseen Elhamin Piet Ost Valérie Fonteyne Martijn Swimberghe Pieter Deseyne Wilfried De Neve Fréderic Duprez Marcus Mareel Chris Monten Annick Van Greveling Tom Vercauteren Leen Paelinck Gilles Defraene Rita Aerts Soumia Arredouani Maarten Lambrecht Ben Vanneste Roxana Draghici Frank A. Giordano Carsten Herskind Marlon R. Veldwijk Irmgard Helmbold Ulrich Giesche Petra Stegmaier Christian Weiß Thomas Blaschke Burkhard Neu Laura Lozza B. Avuzzi S. Morlino Claudia Sangalli Marzia Franceschini Belina Rodriguez-Lage Juan Fernández‐Tajes Olivia Fuentes-Ríos Isabel Domínguez-Rios Irene Fajardo-Paneque Paloma Sosa‐Fajardo Laura Torrado-Moya Mónica Ramos-Albiac Alexandra Giraldo M. Altabas Bibiana Piqué-Leiva David García-Relancio Alejandro Seoane-Ramallo Samuel Lavers Simon K. Wright

REQUITE aimed to establish a resource for multi-national validation of models and biomarkers that predict risk late toxicity following radiotherapy. The purpose this article is provide summary descriptive data.

10.1016/j.radonc.2019.04.034 article EN cc-by-nc-nd Radiotherapy and Oncology 2019-05-27
 Best Current Practice and Research Priorities in Active Surveillance for Prostate Cancer—A Report of a Movember International Consensus Meeting
OPENALEX - Publications 
Caroline M. Moore Lauren E. King John Withington Mahul B. Amin Mark Andrews and 36 more Erik Briers Ronald C. Chen Francis I Chinegwundoh Matthew R. Cooperberg Jane Crowe Antonio Finelli Margaret I. Fitch Mark Frydenberg Francesco Giganti Masoom A. Haider John Freeman Joseph J. Gallo S. Julian Gibbs Anthony Henry Nicholas D. James Netty Kinsella Thomas Lam Mark Lichty Stacy Loeb Brandon A. Mahal Ken Mastris Anita Mitra Samuel William David Merriel Theodorus van der Kwast Mieke Van Hemelrijck Nynikka R. Palmer Catherine Paterson Monique J. Roobol Phillip Segal James A. Schraidt Camille E. Short M. Minhaj Siddiqui Clare M. Tempany Arnaud Villers Howard Wolinsky Steven MacLennan

Active surveillance (AS) is recommended for low-risk and some intermediate-risk prostate cancer. Uptake practice of AS vary significantly across different settings, as does the experience surveillance-from which tests are offered, to levels psychological support.To explore current best determine most important research priorities in cancer.A formal consensus process was followed, with an international expert panel purposively sampled participants a range health care professionals...

10.1016/j.euo.2023.01.003 article EN cc-by European Urology Oncology 2023-01-28
Coming Soon ...